2022 Spring Meetings

Spring Semester, 2022

January 28: 

We will read and discuss the paper by Degtyarev et al. (2020).

References: Degtyarev et al. (2020). Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials—Application of the Estimand Framework. Statistics in Biopharmaceutical Research, 12(4):427-437.

February 18: 

Are restricted mean survival time methods especially useful for noninferiority trials?

References: Freidlin et al. Are restricted mean survival time methods especially useful for noninferiority trials? Clinical Trials, https://doi.org/10.1177/1740774520976576 

February 25: 

No meeting. ENAR webinar on Survival Analysis & Transmission Dynamics.

March 11: 

Michelle Sonnenberger leads a discussion on Bayesian survival analysis methods. 

References: Alvares et al. Bayesian survival analysis with BUGS. Statistics in Medicine. 2021;40:2975–3020.

March 18 (postponed): 

We will talk about relative survival analysis, which is commonly used to estimate the effect of a particular disease on mortality when the cause of death is not reliably known. 

References: Pohar Perme, M., Stare, J., Esteve, J. (2012). On estimation in relative survival. Biometrics 68, 113-120.

March 24:

(LiDS) Webinar on Joint modeling of longitudinal/survival data, 10:00 a.m. – 1:00 p.m. CDT

Registration: www.amstat.org/education/web-based-lectures#JMLSD

April 8: 

References: Michael P. Fay, Erica H. Brittain, Michael A. Proschan, Pointwise confidence intervals for a survival distribution with small samples or heavy censoring, Biostatistics, Volume 14, Issue 4, September 2013, Pages 723–736, https://doi.org/10.1093/biostatistics/kxt016

April 15: 

Presentation by Fang-Shu Ou from the Mayo Clinic on Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials

References: Ou FS, Tang J, An MW, Mandrekar SJ. Modeling tumor measurement data to predict overall survival (OS) in cancer clinical trials. Contemp Clin Trials Commun. 2021 Aug 9;23:100827. doi: 10.1016/j.conctc.2021.100827.

April 20: 

Biostatistics Division Seminar by Dr. Yifei Sun from Columbia University.

Reference: Sun Y, Chiou SH, Wu CO, McGarry M, Huang C-Y. Dynamic risk prediction using survival tree ensembles with application to cystic fibrosis. arXiv:2011.07175

April 29: 

Reference: Mehrotra DV, Marceau West R. Survival analysis using a 5-step stratified testing and amalgamation routine (5-STAR) in randomized clinical trials. Stat Med. 2021 Aug 30;40(19):4341-4343. doi: 10.1002/sim.9116. Epub 2021 Jun 22. Erratum for: Stat Med. 2020 Dec 30;39(30):4724-4744. PMID: 34157789.